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Abstract: Treatment-as-prevention is a term used to describe an HIV prevention method that uses antiretroviral 
treatment to minimize the chance of HIV transmission, with the idea that treatment can decrease the viral load of those 
infected to a level where transmission risk is minimal. However, for treatment-as-prevention to be a success, individuals 
must get tested, know their status, seek care, and adhere to their antiretroviral regimen. Communication plays a role in 
each of these steps, as communication can be used to create demand for health-seeking behavior and as a means to 
increase quality and support on the supply side, at the clinic and community level. From the demand side, 
communication has played a role in convincing people to get tested and obtain their results, in ensuring treatment 
access, linking those infected to care, and addressing stigmatizing attitudes that may prevent individuals from taking 
these actions. On the supply side, communication has been shown to mobilize community care and support and 
increase the quality of patient-provider interaction, which in turn can improve adherence. Finally, communication has 
played an integral role in structural issues related to treatment-as-prevention, including the assurance of adequate 
supplies, including HIV testing kits, anti-retrovirals, and condoms. 
Keywords: Treatment, prevention, communication. 
Public health efforts to reduce the spread of 
HIV/AIDS are undergoing a major shift, from the ABCs 
for sexual transmission (abstinence, being faithful, and 
condom use) and avoidance of shared injection 
equipment for parenteral transmission, to an increased 
emphasis on biomedical approaches. These include 
the use of antiretroviral (ARV) drugs for pre- and post-
exposure prophylaxis. Treatment-as-prevention, the 
notion that treatment of HIV-positive individuals with 
ARVs radically reduces their infectiousness, with 
potentially large population-level implications for 
reductions in incidence, is increasingly being embraced 
as a promising approach in ending the epidemic [1-3].  
Numerous investigators have argued for the 
potential contributions of the social and behavioral 
sciences for maximizing the impact of treatment-as-
prevention [4-8]. Realizing the full potential of 
treatment-as-prevention requires achieving viral load 
suppression in the largest possible proportion of HIV 
infected individuals. This, in turn, entails several 
sequential requirements: the so-called “cascade of HIV 
care” [9]. HIV infected individuals must be identified 
through testing; once diagnosed, they must be linked to 
and retained in care that includes viral load and CD4 
monitoring. When appropriate, they must be given  
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ARVs; they must adhere to the greatest possible extent 
to their ARV regimens; and those regimens must be 
adapted as necessary in response to side effects and 
inadequate viral control. Unfortunately, there are 
decrements at every step in this process. Not all HIV 
infected individuals get tested, not all of those who 
learn their status are linked to care, and so on [1, 9, 
10]. Different impediments operate at each stage of the 
cascade, and one way to classify the stages in the 
cascade is through a supply and demand lens. The 
impediments to the cascade occur on both the supply 
and demand sides: critical infrastructure must be 
established and maintained to ensure an adequate 
supply of testing kits, medications, and human 
resources, while at the same time, individuals must be 
persuaded to get tested, to remain in care, and to 
adhere to ARV regimens. 
In the context of the AIDS epidemic, communication 
is an essential part of any comprehensive program that 
includes both services (medical, social, psychological 
and spiritual) and commodities (condoms, needles and 
syringes). Before individuals and communities can 
reduce their level of risk or change their behaviors, they 
must first understand basic facts about HIV/AIDS, 
adopt key attitudes, learn the necessary skills to reduce 
risk of exposure and be given access to appropriate 
products and services. They must also perceive their 
environment as supporting safer behaviors, as well as 
supportive of seeking appropriate treatment for 
4     Journal of Therapy and Management in HIV Infection, 2013, Vol. 1, No. 1 Limaye et al. 
prevention, care and support. In this paper we focus on 
the specific roles that communication science can play 
in bolstering treatment-as-prevention on both the 
supply and demand sides and at several steps along 
the cascade of HIV care. 
THE DEMAND SIDE 
Communication interventions can play important 
roles in generating demand for HIV testing. These 
interventions take a variety of forms (mass media, 
community or individually oriented), and can focus on a 
variety of messages about who should get tested (risk 
perception), why testing is important (motivation), what 
to expect (fear reduction) and where to find testing 
services (increased efficacy). Exposure to campaigns 
addressing these informational needs in various 
countries has been significantly associated with 
increases in HIV testing [11, 12]. Communication 
interventions have also played an integral role in 
decreasing stigma [13-15], a major barrier to testing in 
many countries [16, 17]. Specifically among married 
men or men in long-term relationships, fear of partner 
abandonment, loss of social status and workplace 
discrimination [17], for example, can all too easily deter 
individuals from learning their status. 
Communication interventions can also play an 
essential demand-side role at other steps of the HIV 
care cascade. A communication campaign in Uganda 
provided adult caregivers with critical information on 
accessing treatment and caring for HIV positive 
children [18]. In Malawi and Ethiopia, radio diaries 
featuring PLHAs have been used effectively to share 
experiences on coping with treatment challenges [14]. 
Additionally, enhanced patient-provider communication 
has shown to have positive impacts on patient health 
behavior, as it can result in greater patient satisfaction, 
adherence to treatment plans,
 
and improved health 
outcomes, such as higher health status, emotional 
health, and symptom relief [19]. Communication 
interventions can increase the quality of interpersonal 
communication between the patient and health 
professional, a factor proven to be of critical importance 
in ART adherence from both the patient and health 
professional perspective [20]. 
At the community level, once a diagnosis of 
HIV/AIDS has been made and treatment has been 
initiated, the community takes a major responsibility in 
providing a continuum of care and support [21]. 
Communication interventions in the form of community 
mobilization can encourage frequent interpersonal 
communication with household members as well as 
religious and traditional leaders, and by providing 
counseling to those infected and affected, community 
health workers invariably increase community 
awareness, which in turn can reduce stigma and 
increase the uptake of service utilization [22]. 
Communication interventions can play a valuable role 
in sensitization and subsequent involvement in 
HIV/AIDS awareness and education of not only health 
personnel, traditional healers and traditional birth 
attendants, but other key community members 
normally not involved in health issues such as political, 
community and religious leaders, teachers, 
associations, and other representatives of key 
grassroots community groups [23, 24]. 
THE SUPPLY SIDE 
Demand-generation interventions may have little 
effect, however, or may even be counterproductive, if 
they cause spikes in demand that outstrip supply. This 
happened recently in Malawi due to an inadequate 
supply of HIV testing kits [25]. Similarly, problems with 
the supply of ARVs have been a major impediment to 
treatment-as-prevention in numerous countries [26-28]. 
In Malawi, the dependence on one ARVs supplier has 
led to an absence of buffer stock, and the lack of the 
existence of a reliable system that has the ability to 
offer treatment to greater numbers of infected people 
has impacted ART uptake [28]. In Cote d’Ivoire, facility-
level stock outs have influenced treatment 
discontinuation [27]. In areas where physicians are 
scarce – such as Mozambique, DRC, India, and 
Myanmar – expanded access to ARVs is further 
constrained because nurses and other non-physician 
health workers are not allowed to initiate ART [26]. In 
many countries (Cameroon, DRC, CAR, Guinea, 
Mozambique, Myanmar and Lesotho), policies do not 
allow for multi-month ART refills [26].  
Expanding access to ARVs is dependent upon 
leadership at the country level. A form of 
communication – advocacy – comprises collective 
action to make resource allocations to support the 
expansion of medicines, testing and prevention [29]. In 
countries where there is poor access to health care, 
low spending on health, and political instability, 
advocacy is a critical component to guarantee the 
resources necessary to sufficiently address the 
epidemic [30]. Advocacy can play a key role in 
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expanding access to ARVs by facilitating or demanding 
the development and implementation of policies that 
would allow and encourage non-physicians in 
community health clinics to offer ART services as well 
as provide multi-month ART refills.  
In addition, advocacy can push for targeting priority 
populations for scale-up, such as serodiscordant 
couples, MSM, pregnant women, and those with CD4 
counts of less than 350 [31]. HIV advocacy can also be 
utilized to build the political will necessary to ensure 
financial, technical and human resources required for 
treatment-as-prevention to work [26, 28]. Brazil’s 
success in providing free and universal ARV access, 
during a time when experts recommended that 
resource-poor countries focus on prevention instead of 
treatment, highlights the lead role played by state-
based organizations in advocating for appropriate 
policies regarding medicine supply as well as the 
importance of constructing alliances [32]. 
Although considered a promising approach in 
ending the epidemic, treatment-as-prevention presents 
a number of challenges, including resource constraints, 
logistical hurdles, emergence of drug-resistant viral 
strains, adherence to therapy regimens, and risk 
compensation [33]. We suggest that communication is 
important and relevant at all stages in the continuum, 
and scientists, health care providers, policy makers, 
and communities should harness the power of 
communication to fully realize the individual and public 
health benefits of treatment-as-prevention. In this 
broader context, we urge the public health community 
to think about treatment drugs not as the magic bullet 
for prevention, but rather as a key component that, 
when combined with sound communication practices, 
can play a significant role in reducing new infections. 
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